Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 

HRT and cancer

Your risk of cancer is influenced by the genes you inherit from your parentsHigh levels of our own natural hormones can increase our risk of cancer. But some medical treatments can also increase our hormone levels, including hormone replacement therapy (HRT) and the contraceptive Pill.

This page will talk about HRT, how it affects your cancer risk, and how you can weigh up the risks. You can read information about the Pill and cancer risk elsewhere in this section.

What is hormone replacement therapy (HRT)?

After menopause, a woman’s ovaries stop producing the hormone oestrogen. As a result, she may experience menopausal symptoms including hot flashes and mood swings.

Hormone replacement therapy, or HRT, treats these symptoms by boosting the body with more female sex hormones. There are three types of HRT:

  • Oestrogen-only HRT, which only contains oestrogen
  • Tibolone HRT, which is a synthetic form of oestrogen
  • Combined HRT, which contains oestrogen and progestagen, another female sex hormone.

HRT and cancer

The evidence that HRT can cause some types of cancer is strong. It includes a study of one million women, run by Cancer Research UK scientists, which has shown that different types of HRT can increase the risk of different cancers. Overall, around 1,700 cases of cancer in the UK each year are linked to HRT, including about 1,500 cases of breast cancer.

Breast cancer

The risk of developing breast cancer is increased for women who are using combined HRT, and may also be increased for users of oestrogen-only HRT. The Million Women Study results suggested that women who are using combined HRT have double the risk of breast cancer compared to non-users. And if they use HRT for over 10 years, their risks are even higher.

Once a woman stops using HRT, her risk of breast cancer will start to drop back down again. It takes about 5 years to go back to the same risk as before she started using HRT.

Breast cancer is much more common than either ovarian or womb cancer. This means that, if you look at the total effect of HRT on these types of cancer, combined HRT is linked to more cases than oestrogen-only HRT, because of its effect on the risk of breast cancer.

Womb cancer

Oestrogen-only HRT and tibolone can increase the risk of womb cancer.

The picture for combined HRT is a bit more complicated. There is evidence that the progestagen part of combined HRT can counteract the cancer-causing effects of the oestrogen part. Studies have shown that the more days per month a woman uses progestagen, as part of combined HRT, the less the increase in risk of womb cancer. At the moment there isn't enough research to say whether, above a certain dose, the progestagen can outweigh the oestrogen and actually reduce the risk of womb cancer overall.

Ovarian cancer

Use of oestrogen-only HRT increases the risk of ovarian cancer

The evidence about combined HRT is less clear-cut but recent studies suggest that, as with womb cancer, the progestagen part could cancel out some of the cancer-causing effects of the oestrogen part. So all other things being equal, women who use combined HRT have a higher risk of ovarian cancer than non-users, but not as high a risk as women who use oestrogen-only HRT.

Studies have shown that risk of ovarian cancer may increase the longer a woman uses HRT, but it's possible there is no noticeable increase in risk for women who use HRT for only a few years.

Other cancers

HRT may reduce the risk of bowel cancer, but the evidence is mixed. Some scientists have concluded the evidence is stronger for oestrogen-only HRT, but others think combined HRT shows a more convincing link. It's also unclear whether any reduction in the risk of bowel cancer would only last for as long as a woman is using HRT. More research needs to be carried out in this area before this link is confirmed.

Should I take HRT?

Your doctor will be able to help you weigh up the pros and cons of different types of HRT and make the right choice based on your own circumstances. HRT is still an effective short-term treatment for menopausal symptoms, but there are other risks and benefits to take into consideration too.

Using HRT for a few years doesn't greatly increase the risk of cancer. But the longer you stay on HRT, the higher the risk becomes. Stopping HRT treatment means the risk of breast cancer starts to drop back down again. By about 5 years after stopping HRT it falls back to the same risk as for a woman who's never used HRT.

If you are considering starting or stopping HRT, or using it for a long time, you should consider the risks involved and discuss them with your doctor. The issues are different for every woman. The fact that HRT increases the risk of breast cancer may be more important if you have a history of breast cancer in your family.

You can read more about HRT, including risks and benefits not related to cancer, on the NHS Choices website.

No Error

Rate this page:
Submit rating
Rated 5 out of 5 based on 1 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team
Updated: 30 October 2013